Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962713 | Vaccine | 2016 | 8 Pages |
Abstract
HD TIV was more immunogenic than SD TIV in children and young adults with leukemia or ST, but not with HIV. HD TIV was safe and well-tolerated in children and young adults with leukemia, ST, or HIV.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hana Hakim, Kim J. Allison, Lee-Ann Van de Velde, Li Tang, Yilun Sun, Patricia M. Flynn, Jonathan A. McCullers,